Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table from Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia
  1. Home
  2. Publications
  3. Supplementary Table from Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia

Supplementary Table from Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia

Authors:
  • WRWilliam G. Rice
    William G. Rice
  • SHStephen B. Howell
    Stephen B. Howell
  • HZHongying Zhang
    Hongying Zhang
  • NRNasrin Rastgoo
    Nasrin Rastgoo
  • ALAndrea Local
    Andrea Local
  • SKStephen E. Kurtz
    Stephen E. Kurtz
  • PLPierrette Lo
    Pierrette Lo
  • DBDaniel Bottomly
    Daniel Bottomly
  • BWBeth Wilmot
    Beth Wilmot
  • SMShannon K. McWeeney
    Shannon K. McWeeney
  • BDBrian J. Druker
    Brian J. Druker
  • JTJeffrey W. Tyner
    Jeffrey W. Tyner

Open Access
Publisher website
Google Scholar
  • 3 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.22523650
Abstract
Supplementary Table from Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia
Keywords
  • TABLE (DATABASE)
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.